Ahmed Abd Al Aziz, MD1, Nader Sh. Zaki, MD2,Karim G. Moustafa, MD3, M. Fathy Elshaal
Abdrabou N Mashhour, Haitham S.E. Omar, Ramy S. Abdelkader.
Hany MS Mikhail, Mohamed M Raslan, Mohamed Y Elbarmelgi, Ramy S. Abdelkader
Adel Morad Abdallah (M.D.)
Ahmed S.M. Omar, MD
H. Said1, Ahmed Khalil1, Ahmed Fathy Hilal2
Ragai S. Hanna1, George Abdelfady Nashed2, Gamal A Makhlouf 3, Nahed A Makhlouf 4, Manal El Sayed Abdelmooty 5
Ragai S. Hanna1 , George Abdelfady Nashed2,Ashraf, A Helmy 3, Gamal A Makhlouf4, Emad Z.K. Said5, Abdelraouf MS Abdelraouf 6
Ramy Mikhael Nageeb1, *, MD, and Shaban M. Abdel Mageed2, *, MD
Shawki M.K Sharouda1*; Ramy Mikhael Nageeb2*; MD and Shaban M. Abdel Mageed1*, MD
Sherif Abdel Halim MD, MRCS, Hanna Habib MD, Hossam Elsadek MD
Ahmed Morad, MD; Wael A Jumuah, MD; Hanna Habib, MD
Yasser El Ghamrini, MD. Karim Sabry Abdel Samee, MD, MRCS(Ed), Wael Abdel Aziem Gumuah, MD.
Anas Mashal MD; Abdallah Magdy MD,FRCS
Anas Mashal MD, *Abdallah Abdelwahed MD;**Hady Saleh Abou-Ashour, MD,MRCS
Effect of Laparoscopic Sleeve Gastrectomy in Treatment of Type II Diabetes Mellitus
Introduction: Excess body weight can result in Diabetes mellitus, where 90% of all diabetics are type 2
(T2DM). Aim of study: To evaluate the effect of Laparoscopic Sleeve Gastrectomy (LSG) as a method of
treatment of type 2 Diabetes mellitus in morbidly obese patients. Patients and methods: A prospective
study was carried out on 40 diabetic morbidly obese patients who underwent LSG during 1.5 years. The
pre-operative diabetic status, duration of Diabetes, body mass index, the excess weight loss percent (EWL
%) at 12 and 18 months follow-up, and remission or improvement of T2DM were recorded and analyzed.
Pre- and postoperative fasting blood glucose, and HbA1C were measured. In addition, Continuous
Glucose Monitoring (CGM) was performed in each patient to clarify the remission of Diabetes. Results:
The mean age of patients was 40.1±4.7 years. The mean preoperative BMI was 51.2±6.5 Kg/m2
. Postoperative calf DVT and bleeding occurred in 5% of cases. Diabetes resolution occurred in 87.5% of
patients (n = 35), where the blood sugar control started at 3 months and reached to no medication at 6
months for 28 patients and 7 patient reached complete cure at 18 months. Diabetes was controlled on oral
hypoglycemic only and a minimal dose was required in 12.5% of patients(n = 5). The EWL% was 70.2% at
12 months and 72.7% at 18 months. Conclusion: LSG resulted in total remission of T2DM in 87.5% of the
patients and easy control of diabetes in 12.5% of patients, and can be considered a metabolic surgery.
Key words: LSG; Type 2 DM; excess weight loss.